10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel

FSTX Insider Trading (F-star Therapeutics)

Insider Ownership Percentage: 2.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $8,885.22

F-star Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at F-star Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

F-star Therapeutics Share Price & Price History

Current Price: $5.20
Price Change: Price Decrease of -0.23 (-4.24%)
As of 07/30/2021 01:00 AM ET

This chart shows the closing price history over time for FSTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel

F-star Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/2/2021Louis KayitalireInsiderSell1,054$8.43$8,885.22View SEC Filing Icon  
See Full Table
Insider Buying at F-star Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for F-star Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for F-star Therapeutics (NASDAQ:FSTX)

9.47% of F-star Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FSTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

F-star Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2021Point72 Asset Management L.P.75,000$0.81M0.0%N/A0.824%Search for SEC Filing on Google Icon
5/18/2021Verition Fund Management LLC128,994$1.40M0.0%N/A1.418%Search for SEC Filing on Google Icon
5/17/2021EcoR1 Capital LLC46,000$0.50M0.0%N/A0.505%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC138,311$1.50M0.0%-23.9%1.520%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp18,444$0.20M0.0%+76.5%0.203%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC55,000$0.60M0.0%+184.5%0.604%Search for SEC Filing on Google Icon
5/11/2021Acadian Asset Management LLC2,451$27K0.0%-38.7%0.027%Search for SEC Filing on Google Icon
4/23/2021BRYN MAWR TRUST Co10,000$0.11M0.0%N/A0.110%Search for SEC Filing on Google Icon
2/16/2021Endurant Capital Management LP20,445$0.20M0.1%N/A0.474%Search for SEC Filing on Google Icon
2/11/2021Arcadia Investment Management Corp MI3,000$30K0.0%N/A0.069%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC181,789$1.79M0.0%N/A4.211%Search for SEC Filing on Google Icon
2/10/2021Connolly Sarah T.53,001$0.52M0.5%N/A1.228%Search for SEC Filing on Google Icon
2/8/2021Parsons Capital Management Inc. RI23,129$0.23M0.0%N/A0.536%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.44,820$0.44M0.0%N/A1.038%Search for SEC Filing on Google Icon
2/1/2021Atlas Venture Advisors Inc.574,996$5.68M1.3%N/A13.319%Search for SEC Filing on Google Icon
1/15/2021Private Capital Advisors Inc.13,083$0.13M0.0%N/A0.303%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118, is currently being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody targeting CD137 (4-1BB) and PD-L1. The company was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.
Read More on F-star Therapeutics

Today's Range

Now: $5.20
Low: $5.08
High: $5.42

50 Day Range

MA: $7.47
Low: $5.20
High: $9.56

52 Week Range

Now: $5.20
Low: $3.88
High: $15.50

Volume

136,016 shs

Average Volume

109,804 shs

Market Capitalization

$100.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.81

Who are the company insiders with the largest holdings of F-star Therapeutics?

F-star Therapeutics' top insider shareholders include:
  1. Louis Kayitalire (Insider)
10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel